2. A big name in computers, the Taiwanese brand made an entry in the smartphone segment in 2014. It is known for its popular Zenfone series.

Alongside their ROG Scar lineups, Asus are also updating their more mainstream ROG Strix G models for 2025. These Strix Gs G615/G815 are a brand-new designs for the year and share many characteristics ...

Gaming laptops aren’t just for gaming, they pack enough power to handle demanding tasks like video editing and coding. However, finding a laptop that seamlessly transitions from a high-performance ...

Asus stick to their two-year update schedule of their major ROG lineups, and that means early 2025 brings brand-new iterations of their full-size ROG Strix Scar and ROG Strix models. In this article, ...

With the X870E and X870 release now out and available we checked out what it is capable of and what they bring to the table. As we review the ASUS ROG Strix X870E-E Gaming WiFi, one of the top-specced ...

Even though it's been kicking around for a little while now, Asus has yet to top the incredible ROG Zephyrus G15. The 'Republic ... There's a reason why the Asus ROG Strix Scar 17 (2023) comes ...

Moto G15 mobile was launched on 16th December 2024. The phone comes with a 60 Hz refresh rate 6.70-inch touchscreen display (FHD+).Moto G15 comes with 8GB of RAM. The Moto G15 runs Android 15 and is ...

Dell G15 (5525), Alienware m17 R5, Alienware m15 R7, Alienware Aurora Based on AMD Processors Launched ...

If you're interested in getting the very best controller that money can buy for your ROG Ally or ROG Ally X then you really ought to consider the Razer Wolverine V3 Pro.

The Asus ROG Phone 9 is hard to distinguish from the ROG Phone 8, bearing much the same looks. Asus has slowly whittled away some of the most ostentatious aesthetics, which would normally set a ...

Admittedly, you can fill a 512GB SSD fairly quickly these days, but the ROG Ally has a microSD card slot that allows you to expand your storage for cheap. For instance, you can grab a SanDisk ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...